Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $608000.0.

  • Envoy Medical's Other Operating Expenses rose 464.72% to $608000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 337.52%. This contributed to the annual value of $2.5 million for FY2024, which is 85.54% up from last year.
  • Latest data reveals that Envoy Medical reported Other Operating Expenses of $608000.0 as of Q3 2025, which was up 464.72% from $595000.0 recorded in Q2 2025.
  • Envoy Medical's 5-year Other Operating Expenses high stood at $1.5 million for Q1 2022, and its period low was $106000.0 during Q3 2022.
  • Moreover, its 4-year median value for Other Operating Expenses was $595000.0 (2025), whereas its average is $681429.5.
  • Within the past 5 years, the most significant YoY rise in Envoy Medical's Other Operating Expenses was 45471.7% (2023), while the steepest drop was 6333.32% (2023).
  • Quarter analysis of 4 years shows Envoy Medical's Other Operating Expenses stood at $1.0 million in 2022, then dropped by 27.9% to $747000.0 in 2023, then fell by 9.64% to $675000.0 in 2024, then dropped by 9.93% to $608000.0 in 2025.
  • Its Other Operating Expenses was $608000.0 in Q3 2025, compared to $595000.0 in Q2 2025 and $584000.0 in Q1 2025.